These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6611193)

  • 41. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
    Ohata H; Shibasaki T
    Peptides; 2004 Oct; 25(10):1703-9. PubMed ID: 15476937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
    Diamant M; Kashtanov SI; Fodor M; de Wied D
    Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corticotropin-releasing factor-binding protein (CRF-BP) inhibits CRF- and urotensin-I-mediated activation of CRF receptor-1 and -2 in common carp.
    Manuel R; Metz JR; Flik G; Vale WW; Huising MO
    Gen Comp Endocrinol; 2014 Jun; 202():69-75. PubMed ID: 24769042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of corticotropin-releasing factor, neurohypophyseal peptides, and catecholamines on pituitary function.
    Rivier C; Vale W
    Fed Proc; 1985 Jan; 44(1 Pt 2):189-95. PubMed ID: 2981740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.
    Barker DM; Corder R
    Br J Pharmacol; 1999 Jan; 126(1):317-25. PubMed ID: 10051151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural homology of corticotropin-releasing factor, sauvagine, and urotensin I: circular dichroism and prediction studies.
    Pallai PV; Mabilia M; Goodman M; Vale W; Rivier J
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6770-4. PubMed ID: 6606178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
    Boorse GC; Denver RJ
    Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin.
    Spinedi E; Negro-Vilar A
    Neuroendocrinology; 1983 Dec; 37(6):446-53. PubMed ID: 6318148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microinfusion of corticotropin-releasing factor into the nucleus accumbens shell results in increased behavioral arousal and oral motor activity.
    Holahan MR; Kalin NH; Kelley AE
    Psychopharmacology (Berl); 1997 Mar; 130(2):189-96. PubMed ID: 9106918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studies.
    Familari M; Smith AI; Smith R; Funder JW
    Neuroendocrinology; 1989 Aug; 50(2):152-7. PubMed ID: 2550836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3',5'-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase.
    Rossant CJ; Pinnock RD; Hughes J; Hall MD; McNulty S
    Endocrinology; 1999 Apr; 140(4):1525-36. PubMed ID: 10098484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural evolution of urotensin-I: reflections of life before corticotropin releasing factor.
    Lovejoy DA
    Gen Comp Endocrinol; 2009 Oct; 164(1):15-9. PubMed ID: 19393654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress.
    Ono N; Bedran de Castro JC; McCann SM
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3528-31. PubMed ID: 2987931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct regulation of GnRH transcription by CRF-like peptides in an immortalized neuronal cell line.
    Tellam DJ; Perone MJ; Dunn IC; Radovick S; Brennand J; Rivier JE; Castro MG; Lovejoy DA
    Neuroreport; 1998 Oct; 9(14):3135-40. PubMed ID: 9831440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The corticotropin-releasing factor system as a mediator of the appetite-suppressing effects of stress in fish.
    Bernier NJ
    Gen Comp Endocrinol; 2006 Mar; 146(1):45-55. PubMed ID: 16410007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
    Primus RJ; Yevich E; Baltazar C; Gallager DW
    Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery.
    Schilling L; Kanzler C; Schmiedek P; Ehrenreich H
    Br J Pharmacol; 1998 Nov; 125(6):1164-71. PubMed ID: 9863643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urotensin I-CRF-Urocortins: a mermaid's tail.
    Pittman QJ; Hollenberg MD
    Gen Comp Endocrinol; 2009 Oct; 164(1):7-14. PubMed ID: 19409389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands.
    Krause K; Schnitger A; Fimmel S; Glass E; Zouboulis CC
    Horm Metab Res; 2007 Feb; 39(2):166-70. PubMed ID: 17326013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.